126.00
+0.80%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About IVF Hartmann Holding
Its shares trade on SIX under the ticker VBSN.SW. It has been listed since 16 July 2012. In the fiscal year to 31 December 2025, it reported revenue of CHF 161.7m and net income of CHF 18.3m. At that date it held total assets of CHF 196.1m and shareholders' equity of CHF 155.4m.
IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 16 Jul 2012
- Employees
- 360
Leadership
Pay as last reported
- Ms. Cornelia BossicardPresident of the BoardCHF 141,049
- Dr. Claus MartiniChief Executive Officer, Member of the Management BoardCHF 699,718
- Mr. Oliver NeubrandVice President of the Board
- Dr. Hannes LeuChief Financial Officer, Member of the Management Board
- Dr. Aldo SchellenbergNon-Executive Member of the Board of DirectorsCHF 33,931
- Mr. Martin WaltherNon-Executive Member of the Board of Directors, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- IVF Hartmann Holding AG has several key strengths that contribute to its success and competitive advantage. These strengths include:
- Despite its strengths, IVF Hartmann Holding AG also faces certain weaknesses that need to be addressed. These weaknesses include:
- IVF Hartmann Holding AG can capitalize on various opportunities to further expand its business and enhance its market position. These opportunities include:
- IVF Hartmann Holding AG faces several threats that could pose challenges to its growth and profitability. These threats include:
Weaknesses
- Despite its strengths, IVF Hartmann Holding AG also faces certain weaknesses that need to be addressed. These weaknesses include:
- IVF Hartmann Holding AG can capitalize on various opportunities to further expand its business and enhance its market position. These opportunities include:
- IVF Hartmann Holding AG faces several threats that could pose challenges to its growth and profitability. These threats include:
Opportunities
- IVF Hartmann Holding AG can capitalize on various opportunities to further expand its business and enhance its market position. These opportunities include:
- IVF Hartmann Holding AG faces several threats that could pose challenges to its growth and profitability. These threats include:
Threats
- IVF Hartmann Holding AG faces several threats that could pose challenges to its growth and profitability. These threats include:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.